Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.
about
Direct demonstration that receptor crosslinking or aggregation is important in insulin actionSelection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor.Insulin receptor antibodies inhibit insulin uptake by the liver: in vivo 123I-insulin scintigraphic scanning and in vitro characterization in autoimmune hypoglycemia.Type B insulin resistance developing during interferon-alpha therapy.Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance.Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.Autoimmune hypoglycemia in a patient with characterization of insulin receptor autoantibodiesDirect method for detection and characterization of cell surface receptors for insulin by means of 125I-labeled autoantibodies against the insulin receptor.Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinityState of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytesDirect demonstration of glycosylation of insulin receptor subunits by biosynthetic and external labeling: evidence for heterogeneity.Successful treatment of type B insulin resistance with rituximabNonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetesFluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.High affinity binding of 125I-angiotensin II to rat glomerular basement membranes.Membrane receptors for hormones and neurotransmitters.Surface redistribution of 125I-insulin in cultured human lymphocytesAntibody against the insulin receptor causes disappearance of insulin receptors in 3T3-L1 cells: a possible explanation of antibody-induced insulin resistance.Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravisMonoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes.Prolactin-like activity of anti-prolactin receptor antibodies on casein and DNA synthesis in the mammary gland.Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factorGenetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase.Myotubes derived from human-induced pluripotent stem cells mirror in vivo insulin resistance.Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts.Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytesEffects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia.Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibodyAntibodies raised against purified beta-adrenergic receptors specifically bind beta-adrenergic ligands.An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity.Analysis of the insulin receptor by anti-receptor antibodies and flow cytometry.Use of anti-idiotypic antibodies as cell-surface receptor probes.Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism.
P2860
Q24616924-278A0013-5511-4758-BFE1-DDACE060178DQ30463953-77BCACDE-FC7B-4770-AA9D-5515593EE541Q32056639-B0A57E98-9E25-4EA5-B9A4-926F93506738Q33418525-0573BE78-D2D8-4177-BF43-4AB257150F68Q33982304-F084AD45-BF88-458D-8AF6-DA56E75A83E2Q34032021-C762CEBF-708A-4781-B7A0-0410ACBFEF6CQ34828931-5A098CEC-909C-430C-815E-8659CDE447BFQ35036821-CFBDBD60-44A3-42F0-B1DE-16764768ED19Q35095516-3009B2D7-F3D2-40E5-B7D6-35238D6F8136Q35233754-30971288-9F72-47D6-B239-B39CCC5862B6Q35367123-2F5E723B-EF62-4F2B-ADD4-2F5C714AAE17Q35423024-62572D2C-0BA9-43E1-B812-E6784CBF5E88Q35454571-22A638DF-AD6D-4361-972E-BCA4889AD456Q35578301-41707D67-1A91-4948-BDCD-B30F432E5398Q35590467-CF8D3AA0-0542-4A65-8E2D-67BAF5D0EB1CQ35905106-B6BC0A2F-5D92-4A3A-88B5-BA7DE7052337Q35905356-B6234F06-E342-4133-945F-DA62DE8EEC4DQ35905468-9380DE32-3BD8-4636-AB79-B18072BE051EQ36198388-F8F53FE8-0BE4-47EB-AD6C-C33961606F59Q36205471-0F31C618-1E11-4874-A559-69F5787B7545Q36257870-803B4E37-1B29-4FEA-8BDC-1A00FF320217Q36307151-5F9BB542-F1FE-4E9B-BB00-93F9E1F995D4Q36323412-1C3E75C4-2CF1-4640-965E-B870299854CEQ36367219-41FB47E9-509F-4625-91A0-C62DDEEDDD82Q36382477-8D6CC6B5-AF4A-46C0-9D0D-7BC5C629BDA1Q36383082-2CD023B5-9E01-4B07-A271-8504D7F8726CQ36398632-377850E9-0EEF-4284-B9F4-634CB7F94688Q36419578-506F23AB-1D47-4A0A-A578-557142492141Q36607500-1F4D2460-486A-4022-80E2-0753C7AC09FBQ37024018-EF20F7C2-2977-4CE7-8CB1-EB97A6379C26Q37024939-5BDB97E6-FD79-43B9-B5E2-23C79065F99DQ37047248-C2467876-D1AC-4A66-87EF-069FFF844C40Q37048342-65611184-86AF-4D9F-A11B-04B9FE145877Q37054117-46D8FC6D-F75D-4ABE-A994-65B802E704FAQ37315425-04421F96-D2B9-486B-BD6A-63E3036A11AEQ37330406-871B02CA-38CB-459A-8E0C-F6744546F6AAQ37537629-A22D5494-06B4-4C16-92CD-03A3CEEA907FQ37578888-345BA28E-AC5E-472B-AB26-CF801C1FB4B5Q37586987-E6EDB50D-8B95-4312-8055-88B9E93CBF05Q37591191-26DB08F6-76A4-43D1-9646-AB8BA38F6140
P2860
Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.
description
1975 nî lūn-bûn
@nan
1975 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Antibodies that impair insulin ...... ith severe insulin resistance.
@ast
Antibodies that impair insulin ...... ith severe insulin resistance.
@en
Antibodies that impair insulin ...... ith severe insulin resistance.
@nl
type
label
Antibodies that impair insulin ...... ith severe insulin resistance.
@ast
Antibodies that impair insulin ...... ith severe insulin resistance.
@en
Antibodies that impair insulin ...... ith severe insulin resistance.
@nl
prefLabel
Antibodies that impair insulin ...... ith severe insulin resistance.
@ast
Antibodies that impair insulin ...... ith severe insulin resistance.
@en
Antibodies that impair insulin ...... ith severe insulin resistance.
@nl
P2093
P2860
P356
P1433
P1476
Antibodies that impair insulin ...... ith severe insulin resistance.
@en
P2093
P2860
P356
10.1126/SCIENCE.170678
P407
P577
1975-10-01T00:00:00Z